亞太地區目標定序市場:按應用、按產品類型、靶向序列捕獲方法、按目標捕獲類型、按最終用戶、按國家/地區 - 分析和預測 (2024-2033)
市場調查報告書
商品編碼
1614806

亞太地區目標定序市場:按應用、按產品類型、靶向序列捕獲方法、按目標捕獲類型、按最終用戶、按國家/地區 - 分析和預測 (2024-2033)

Asia-Pacific Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033

出版日期: | 出版商: BIS Research | 英文 60 Pages | 商品交期: 1-5個工作天內

價格

2023年亞太地區標靶定序市場規模為5.742億美元。

預計2024年至2033年該市場將以14.35%的複合年成長率成長,2033年達到21.755億美元。亞太地區標靶定序市場競爭激烈,現有企業和新興企業在爭奪市場佔有率。未來幾年,市場預計將持續發展和轉型,機會與挑戰並存,因此密切關注市場的動態和快速變化至關重要。

主要市場統計數據
預測期 2024-2033
2024年評估 6.509 億美元
2033 年預測 21.755 億美元
複合年成長率 14.35%

對經濟實惠且高度準確的測序技術的需求不斷成長、精準醫學的使用不斷增加以及基因組學的進步都促進了亞太地區靶向定序市場的顯著成長。特定基因或感興趣區域的標靶定序正變得越來越流行,因為它是全基因組定序的經濟有效的替代方案。中國、日本、韓國和印度等國家由於強力的政府資助、不斷擴大的研究舉措和不斷擴大的生物技術領域而主導了市場。

癌症和遺傳性疾病等慢性疾病的增加增加了標靶定序在臨床診斷和個人化治療方法中的應用。由於次世代定序(NGS)平台的技術開拓以及學術機構和公司之間的夥伴關係不斷增強,該市場正在不斷擴大。此外,亞太地區人口眾多,加上基於基因組學的醫療保健意識不斷增強,為市場相關人員提供了巨大的商機。

此外,靶向定序因其成本效益而對臨床和研究應用特別有吸引力,可以更深入地了解遺傳變異,同時簡化資料分析。由於基因組研究投資的增加,亞太地區標靶定序市場預計將顯著成長,有助於該地區精準醫學和基因組研究的進步。

該報告研究了亞太地區目標定序市場,並按應用、產品類型、靶向序列捕獲方法、目標捕獲類型、最終用戶、國家和市場趨勢提供了市場概況。

目錄

執行摘要

第1章 市場

  • 趨勢:當前和未來的影響評估
  • 標靶定序工作流程
  • 研究發展回顧
  • 監管狀況
  • 市場動態:概述

第2章 區域

  • 區域概況
  • 促進因素和抑制因素
  • 亞太地區
    • 區域概況
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 其他

第3章市場-競爭基準化分析與公司概況

  • 未來展望
  • 競爭格局
    • BGI Group
    • Daicel Corporation
    • Takara Bio Inc.

第4章調查方法

Product Code: BHP2457SS

Introduction to Asia-Pacific Targeted Sequencing Market

The Asia-Pacific targeted sequencing market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033. The APAC targeted sequencing market is fiercely competitive, with both established players and emerging companies vying for market share. It will be crucial to keep an eye on the market's dynamic and quickly changing landscape in the upcoming years as a result of its anticipated growth and transformation, which present both opportunities and challenges.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$650.9 Million
2033 Forecast$2,175.5 Million
CAGR14.35%

The growing demand for affordable, high-accuracy sequencing technologies, the growing use of precision medicine, and genomics advancements are all contributing to the notable growth of the APAC targeted sequencing market. Because it provides a cost-effective and efficient substitute for whole genome sequencing, targeted sequencing-which concentrates on particular genes or regions of interest-is becoming more and more popular. Thanks to strong government funding, growing research initiatives, and the expanding biotechnology sector, nations like China, Japan, South Korea, and India are dominating the market.

The use of targeted sequencing for clinical diagnostics and individualized treatment regimens has increased due to the rise in chronic diseases, such as cancer and genetic disorders. The market is growing as a result of technological developments in next-generation sequencing (NGS) platforms and growing partnerships between academic institutions and business entities. Additionally, the APAC region's large population, coupled with growing awareness about genomics-based healthcare, creates significant opportunities for market players.

Furthermore, targeted sequencing is particularly appealing for clinical and research applications due to its cost-effectiveness, which allows for deeper understanding of genetic variations while simplifying data analysis. The APAC targeted sequencing market is expected to grow significantly as genomics research investments rise, contributing to the advancement of precision medicine and genomic research in the region.

Market Segmentation

Segmentation 1: by Application

  • Cancer
  • Reproductive Health
  • Hereditary Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Other Applications

Segmentation 2: by End User

  • Diagnostic and Clinical Laboratories
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other End Users

Segmentation 3: by Product Type

  • Instruments
  • Services
  • Kits/Panels and Assays
  • Others

Segmentation 4: by Target Enrichment Method

  • Hybridization Capture
  • Amplicon Sequencing
  • Other Target Enrichment Methods

Segmentation 5: by Target Capture

  • Targeted DNA Sequencing
  • Targeted RNA Sequencing
  • Other Types of Target Capture

Segmentation 6: by Country

  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some of the prominent companies in this market are:

  • BGI Group
  • Daicel Corporation
  • Takara Bio Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Number of Targeted Sequencing Products and Services in the Market
    • 1.1.2 Increasing Synergistic Partnerships between Market Players
  • 1.2 Targeted Sequencing Workflow
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Increasing Demand for High Depth of Coverage in Sequencing
      • 1.5.1.2 Cost and Data Management Benefits of Targeted Sequencing as Compared to WGS
    • 1.5.2 Market Restraints
      • 1.5.2.1 Lack of Advanced Genomic Testing Centers
      • 1.5.2.2 Lack of Knowledge about New Genes
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Increasing Use in Clinical Research and Trials for Better Disease Pathogenesis and/or Clinical Relevance
      • 1.5.3.2 Increasing Adoption in Targeted Therapeutics in Oncology

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
      • 2.3.1.1 Driving Factors for Market Growth
      • 2.3.1.2 Factors Challenging the Market
    • 2.3.2 Application
    • 2.3.3 Product
    • 2.3.4 China
    • 2.3.5 Application
    • 2.3.6 Product
    • 2.3.7 India
    • 2.3.8 Application
    • 2.3.9 Product
    • 2.3.10 Japan
    • 2.3.11 Application
    • 2.3.12 Product
    • 2.3.13 South Korea
    • 2.3.14 Application
    • 2.3.15 Product
    • 2.3.16 Australia
    • 2.3.17 Application
    • 2.3.18 Product
    • 2.3.19 Rest-of-Asia-Pacific
    • 2.3.20 Application
    • 2.3.21 Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Landscape
    • 3.2.1 BGI Group
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View
    • 3.2.2 Daicel Corporation
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Target Customers
      • 3.2.2.5 Key Personnel
      • 3.2.2.6 Analyst View
    • 3.2.3 Takara Bio Inc.
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products
      • 3.2.3.3 Top Competitors
      • 3.2.3.4 Target Customers
      • 3.2.3.5 Key Personnel
      • 3.2.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Targeted Sequencing Market, $Million, 2024, 2027, and 2033
  • Figure 2: Targeted Sequencing Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacifc Targeted Sequencing Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Asia-Pacifc Targeted Sequencing Market (by Target Enrichment Method), $Million, 2023, 2027, and 2033
  • Figure 5: Asia-Pacifc Targeted Sequencing Market (by Target Capture), $Million, 2023, 2027, and 2033
  • Figure 6: Asia-Pacifc Targeted Sequencing Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 7: Asia-Pacifc Targeted Sequencing Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 8: Key Industrial Developments in Targeted Sequencing Market, 2023
  • Figure 9: Workflow of Targeted Sequencing
  • Figure 10: Targeted Sequencing Market, Number of Patents (by Country), January 2019-February 2024
  • Figure 11: Targeted Sequencing Market (by Year), January 2019-February 2024
  • Figure 12: China Targeted Sequencing Market, $Million, 2023-2033
  • Figure 13: India Targeted Sequencing Market, $Million, 2023-2033
  • Figure 14: Japan Targeted Sequencing Market, $Million, 2023-2033
  • Figure 15: South Korea Targeted Sequencing Market, $Million, 2023-2033
  • Figure 16: Australia Targeted Sequencing Market, $Million, 2023-2033
  • Figure 17: Rest-of-Asia-Pacific Targeted Sequencing Market, $Million, 2023-2033
  • Figure 18: Share of Strategic Initiatives
  • Figure 19: Data Triangulation
  • Figure 20: Top-Down and Bottom-Up Approach
  • Figure 21: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Targeted Sequencing Market, Opportunities
  • Table 3: Targeted Sequencing Market, Trend Analysis
  • Table 4: Some Product Launches in the Targeted Sequencing Market
  • Table 5: Targeted Sequencing Market, Key Partnerships and Collaborations
  • Table 6: Targeted Sequencing Market, Regulatory Landscape
  • Table 7: Impact Analysis of Market Navigating Factors, 2023-2033
  • Table 8: Comparison Between Types of Next-Generation Sequencing Techniques
  • Table 9: Targeted Sequencing Market (by Region), $Million, 2023-2033
  • Table 10: Asia-Pacific Targeted Sequencing Market (by Application), $Million, 2023-2033
  • Table 11: Asia-Pacific Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 12: Asia-Pacific Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 13: Asia-Pacific Targeted Sequencing Market (by Target Enrichment Methods), $Million, 2023-2033
  • Table 14: Asia-Pacific Targeted Sequencing Market (by Type of Target Capture), $Million, 2023-2033
  • Table 15: China Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 16: China Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 17: India Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 18: India Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 19: Japan Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 20: Japan Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 21: South Korea Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 22: South Korea Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 23: Australia Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 24: Australia Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 25: Rest-of-Asia-Pacific Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 26: Rest-of-Asia-Pacific Targeted Sequencing Market (by Product Type), $Million, 2023-2033"